World

WHO boss says vaccine IP waiver not a property ‘snatch’

With lives on the line, Tedros Adhanom Ghebreyesus calls for profits, patents to take a back seat

Updated 5 years ago · Published on 22 Jul 2021 9:30AM

WHO boss says vaccine IP waiver not a property ‘snatch’
WHO Director-General Tedros Adhanom Ghebreyesus said vaccine makers should be offered incentives in return for temporarily waiving intellectual property rights. – AFP pic, July 22, 2021

GENEVA – The World Health Organisation (WHO) yesterday sought to reassure pharmaceutical companies that a proposal to suspend patent rights on Covid-19 vaccines was not a bid to “snatch” their intellectual property(IP) rights.

With more than four million dead and the toll likely to reach much higher, WHO Director-General Tedros Adhanom Ghebreyesus said vaccine makers should be offered incentives in return for temporarily waiving IP rights.

“Of course, we can’t snatch your property,” Tedros said via video link from Tokyo at the start of a meeting with the World Trade Organisation, pharmaceutical companies and global financial institutions.

“With so many lives on the line, profits and patents must come second,” he said, without giving any details on the proposed financial incentives.

Waiving intellectual property rights would help meet the 11 billion doses of vaccine the WHO says are needed to protect 70% of people in every country by mid-2022.

This is the second meeting in Geneva to try to bridge differences on how to increase supply of jabs and cut the vaccine inequity that sees rich countries eyeing booster shots while health workers in poor countries go without.

Of the 1.1 billion doses produced globally in June, “only 1.4% went to Africans, who account for 17% of the global population”, WTO Director-General Ngozi Okonjo-Iweal said in her opening speech.

“Only 0.24% went to people in low-income countries. And both shares declined even further in the first half of July,” she said.

In addition to the suspension of patents, barriers to the trade in vaccine ingredients must be removed and laboratories agree to transfer their technology, Tedros said. – AFP, July 22, 2021

Related News

Malaysia / 2y

Current health ailments not related to AstraZeneca vaccine, says Noor Hisham

Malaysia / 2y

Govt aware of AstraZeneca vaccine side effects when it was deployed, says Noor Hisham

World / 2y

AstraZeneca Covid-19 vaccine to be withdrawn globally

World / 2y

AstraZeneca admits Covishield can cause blood clots, low platelet count

Malaysia / 2y

8.5 million doses of Covid-19 vaccine worth RM505 mil expired since June 1: PAC

Health / 3y

WHO, US health authorities tracking new Covid-19 variant

Spotlight

Trump’s North Korea gamble deepens Asia’s doubts over US alliances

Malaysia

Rayer denies involvement in 'Maha Kali Red Rally', claims name and photo misused

Malaysia

E-Hailing driver charged with attempted murder after allegedly setting worker on fire

Business

Nation’s economic outlook strengthens as leading index signals continued growth

Malaysia

‘No parent wants her child to be remembered this way,’ says mother of 14-year-old Keziah

Malaysia

RM1.96m Penang land probe: Two ‘Datuks’ remain in custody

Business

K8 cargo: Businessman seeks clarification from MOF, Customs, Petronas

Malaysia

PH leaders hold talks as Melaka election plans take shape

Malaysia

Bersama rejects political alliances, vows to go solo in Melaka state election

You may be interested

World

US threatens Iran with ‘greatest financial offensive’

World

Iran warns countries backing new US measures would face ‘Act of War’

World

Foreign tourist injured in bear attack in Japan

World

Canada to hit US goods with dollar-for-dollar tariffs after trade talks collapse

World

Indonesia arrests 72 over forest fires as haze spreads to Malaysia

World

Teen killed in sword attack at Swedish school was a 17-year-old girl

World

AirAsia flight undergoes cleaning after passenger ‘incident’ before Shanghai landing

World

Two police officers among seven killed in wrong-way crash on UK’s A66